GGHC
ADPT icon

Gilder Gagnon Howe & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$315K Sell
22,719
-2,279
-9% -$36.3K ﹤0.01% 243
2025
Q4 		$406K Buy
+24,998
New +$408K ﹤0.01% 239
2024
Q2 		– Sell
-1,245,111
Closed -$4M – 252
2024
Q1 		$4M Buy
1,245,111
+11,597
+0.9% +$44.9K 0.05% 160
2023
Q4 		$6.04M Buy
1,233,514
+9,396
+0.8% +$42.9K 0.08% 140
2023
Q3 		$6.67M Buy
1,224,118
+8,593
+0.7% +$56.8K 0.1% 127
2023
Q2 		$8.16M Buy
1,215,525
+46,005
+4% +$342K 0.11% 127
2023
Q1 		$10.3M Buy
+1,169,520
New +$10.3M 0.17% 105
2022
Q1 		– Sell
-942,666
Closed -$26.5M – 291
2021
Q4 		$26.5M Sell
942,666
-1,027,060
-52% -$31.5M 0.15% 124
2021
Q3 		$67M Sell
1,969,726
-80,237
-4% -$2.9M 0.35% 71
2021
Q2 		$83.8M Sell
2,049,963
-334,242
-14% -$13M 0.41% 68
2021
Q1 		$96M Buy
2,384,205
+9,407
+0.4% +$509K 0.52% 57
2020
Q4 		$140M Sell
2,374,798
-22,481
-0.9% -$1.16M 0.7% 40
2020
Q3 		$117M Sell
2,397,279
-57,990
-2% -$2.44M 0.72% 43
2020
Q2 		$119M Buy
2,455,269
+176,019
+8% +$6.42M 0.93% 30
2020
Q1 		$63.3M Buy
2,279,250
+1,494,052
+190% +$41.7M 0.76% 44
2019
Q4 		$23.5M Sell
785,198
-7,423
-0.9% -$213K 0.24% 93
2019
Q3 		$24.5M Buy
792,621
+200,872
+34% +$8.2M 0.28% 92
2019
Q2 		$28.6M Buy
+591,749
New +$26.2M 0.29% 88

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gilder Gagnon Howe & Co's ADPT Position: Q1 2026 in Review

Gilder Gagnon Howe & Co reduced its Adaptive Biotechnologies (ADPT) stake by 9.1% in Q1 2026, selling an estimated $36.3K and leaving 22,719 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Gilder Gagnon Howe & Co first reported a position in ADPT in Q2 2019 and has held it in 18 quarters since. The position peaked at $140M in Q4 2020. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Gilder Gagnon Howe & Co held 22,719 shares of Adaptive Biotechnologies worth $315K as of Q1 2026.
  • Gilder Gagnon Howe & Co sold 2,279 Adaptive Biotechnologies shares in Q1 2026, an estimated $36.3K.
  • Adaptive Biotechnologies made up ﹤0.01% of Gilder Gagnon Howe & Co's portfolio in Q1 2026, its #243 holding.
  • Gilder Gagnon Howe & Co first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 18 quarters since.
  • Gilder Gagnon Howe & Co's Adaptive Biotechnologies position peaked at $140M in Q4 2020.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.